✦ LIBER ✦

Essential thrombocythemias without V617F JAK2 mutation are clonal hematopoietic stem cell disorders

✍ Scribed by Kiladjian, J-J; Elkassar, N; Cassinat, B; Hetet, G; Giraudier, S; Balitrand, N; Conejero, C; Briere, J; Fenaux, P; Chomienne, C

Book ID: 110056733
Publisher: Nature Publishing Group
Year: 2006
Tongue: English
Weight: 85 KB
Volume: 20
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2404214

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular profile of CD34+ stem/progenit

Molecular profile of CD34+ stem/progenitor cells according to JAK2V617F mutation status in essential thrombocythemia

✍ Catani, L; Zini, R; Sollazzo, D; Ottaviani, E; Vannucchi, A M; Ferrari, S; Bacca 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 160 KB

Transformed essential thrombocytosis wit

Transformed essential thrombocytosis with a JAK2 V617F mutation relapsing as JAK2 mutation-negative leukaemia after allogeneic stem cell transplantation

✍ Au, W Y; Fung, A; Lam, K Y; Lie, A K; Liang, R; Kwong, Y L 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 83 KB

P113 Analysis of polycythemia vera and e

P113 Analysis of polycythemia vera and essential thrombocythemia by lineage specific investigation of JAK2V617F mutation and X-linked clonality assay

✍ P. Jáksó; Z. Nagy; L. Kereskai; D. Alpár; B. Kajtár; L. Pajor 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 48 KB

these two surface proteins and their expression variety with the type of myeloproliferative disease and clinical status. Conclusions: As preliminary data show a reduced expression of fibrinogen receptor and von Willebrand receptor occurred in patients versus controls. Due to the small number of anal

Circulating endothelial cells in essenti

Circulating endothelial cells in essential thrombocythemia and polycythemia vera: correlation with JAK2-V617F mutational status, angiogenic factors and coagulation activation markers

✍ Jacek Treliński; Agnieszka Wierzbowska; Anna Krawczyńska; Agata Sakowicz; Tadeus 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 184 KB

TG101348, a JAK2-selective antagonist, i

TG101348, a JAK2-selective antagonist, inhibits primary hematopoietic cells derived from myeloproliferative disorder patients with JAK2V617F, MPLW515K or JAK2 exon 12 mutations as well as mutation negative patients

✍ Lasho, T L; Tefferi, A; Hood, J D; Verstovsek, S; Gilliland, D G; Pardanani, A 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB

A new MALDI-TOF-based assay for monitori

A new MALDI-TOF-based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD)

✍ Maya Koren-Michowitz; Avichai Shimoni; Asaf Vivante; Luba Trakhtenbrot; Gideon R 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 343 KB